SNST (Aphex BioCleanse Systems) Return-on-Tangible-Asset: 0.00% (As of . 20)


What is Aphex BioCleanse Systems Return-on-Tangible-Asset?

Aphex BioCleanse Systems SNST Return-on-Tangible-Asset is 0.00% as of . 20.

Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Aphex BioCleanse Systems's annualized Net Income for the quarter that ended in . 20 was $ Mil. Aphex BioCleanse Systems's average total tangible assets for the quarter that ended in . 20 was $ Mil. Therefore, Aphex BioCleanse Systems's annualized Return-on-Tangible-Asset for the quarter that ended in . 20 was 0.00%.

The historical rank and industry rank for Aphex BioCleanse Systems's Return-on-Tangible-Asset or its related term are showing as below:

SNST's Return-on-Tangible-Asset is not ranked *
in the Consumer Packaged Goods industry.
Industry Median: 3.39
* Ranked among companies with meaningful Return-on-Tangible-Asset only.

Aphex BioCleanse Systems  (OTCPK:SNST) Return-on-Tangible-Asset Explanation

Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.


Be Aware

Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the company’s earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a company’s tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.


Aphex BioCleanse Systems Return-on-Tangible-Asset Related Terms


Aphex BioCleanse Systems Return-on-Tangible-Asset Historical Data

* Premium members only.

The historical data trend for Aphex BioCleanse Systems's Return-on-Tangible-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aphex BioCleanse Systems Return-on-Tangible-Asset Chart

Aphex BioCleanse Systems Annual Data
Trend
Return-on-Tangible-Asset

Aphex BioCleanse Systems Quarterly Data
Return-on-Tangible-Asset

Aphex BioCleanse Systems Return-on-Tangible-Asset Competitor Comparison

For the Household & Personal Products subindustry, Aphex BioCleanse Systems's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aphex BioCleanse Systems Return-on-Tangible-Asset vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Aphex BioCleanse Systems's Return-on-Tangible-Asset distribution charts can be found below:

* The bar in red indicates where Aphex BioCleanse Systems's Return-on-Tangible-Asset falls into.



Aphex BioCleanse Systems Return-on-Tangible-Asset Calculation

Aphex BioCleanse Systems's annualized Return-on-Tangible-Asset for the fiscal year that ended in . 20 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(A: . 20 )  (A: . 20 )(A: . 20 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(A: . 20 )  (A: . 20 )(A: . 20 )
=/( (+)/ )
=/
= %

Aphex BioCleanse Systems's annualized Return-on-Tangible-Asset for the quarter that ended in . 20 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(Q: . 20 )  (Q: . 20 )(Q: . 20 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(Q: . 20 )  (Q: . 20 )(Q: . 20 )
=/( (+)/ )
=/
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (. 20) net income data.

What does a Return-on-Tangible-Asset of 0.00% mean?
Aphex BioCleanse Systems (SNST) has a Return-on-Tangible-Asset of 0.00% as of . 20. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Aphex BioCleanse Systems and its competitors.
Is Aphex BioCleanse Systems' Return-on-Tangible-Asset too high?
Aphex BioCleanse Systems' current Return-on-Tangible-Asset is 0.00%.
How does Aphex BioCleanse Systems' Return-on-Tangible-Asset compare to competitors?
Aphex BioCleanse Systems' Return-on-Tangible-Asset of 0.00% can be compared against companies in the Consumer Packaged Goods industry. The industry median Return-on-Tangible-Asset is 3.39. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Consumer Packaged Goods company?
The median Return-on-Tangible-Asset among Consumer Packaged Goods companies is 3.39, based on 1,991 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Aphex BioCleanse Systems and its competitors. For the Consumer Packaged Goods industry, the median Return-on-Tangible-Asset is 3.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aphex BioCleanse Systems's current Return-on-Tangible-Asset is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aphex BioCleanse Systems stock overvalued right now?
Aphex BioCleanse Systems (SNST) has a current Return-on-Tangible-Asset of 0.00%. The current Return-on-Tangible-Asset is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Aphex BioCleanse Systems (SNST), the current Return-on-Tangible-Asset is 0.00% as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aphex BioCleanse Systems Business Description

Address 1820 State Road 13, Unit 11-43, Saint Johns, FL, USA, 32259
Aphex BioCleanse Systems Inc is a United States-based company that provides sanitization solutions. It develops and manufactures non-alcohol, non-toxic, and hydrogen-based disinfecting technology. The company produces proprietary hydrogen-based disinfectant and pesticide products known as Hy-IQ Water.